The incidence of osteoporotic fracture increases exponentially throughout life, as does the risk of the devastating consequences of these fractures, including functional decline, institutionalization, mortality, and destitution.1 Adults in their eighth and ninth decades of life are less likely to be screened and treated for osteoporosis than younger individuals. Guidelines for pharmacologic treatment suggest using 10-year fracture risk estimations, but they do not address decision making for patients with life expectancies less than 10 years. Further, existing fracture risk calculators do not include many comorbidities or frailty characteristics common in older adults that influence risk-benefit assessment when considering pharmacologic treatment as a preventive measure for osteoporosis.
Berry SD, Kiel DP, Colón-Emeric C. Hip Fractures in Older Adults in 2019. JAMA. Published online May 10, 2019321(22):2231–2232. doi:10.1001/jama.2019.5453
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: